期刊文献+

一种人巨细胞病毒中和抗体效价快速检测方法的建立 被引量:11

Development of A Method for Rapid Detection of Neutralizing Antibody Titer against Human Cytomegalovirus
原文传递
导出
摘要 目的建立一种人巨细胞病毒(Human cytomegalovirus,HCMV)中和抗体效价检测方法。方法系列稀释的待检样品与等体积HCMV混合,中和反应1 h后,接种MRC-5细胞,37℃孵育过夜,依次加入HCMV anti-IE1单抗、Biotin-SP-Goat antiMouse IgG、Peroxidase-Labeled Streptavidin及底物,对HCMV感染细胞的细胞核进行特异性染色和定位,采集显微图像,计数每孔中感染细胞数。采用Reed-Muench计算样品的中和效价。并对建立的方法进行精密性、耐用性和专属性验证。结果感染HCMV的MRC-5细胞,出现典型的CPE,且其细胞核出现特异性着色颗粒,而未感染的细胞则未出现着色颗粒。该方法重复性检测的变异系数为3.26%,中间精密性检测的变异系数为1.05%;样品与等体积中和病毒液于37℃中和反应55、60和65 min,中和抗体效价差异无统计学意义(P>0.05);水痘病毒感染的MRC-5细胞未出现特异性着色颗粒,10份不同类型的样品与MRC-5细胞共同孵育后,也未出现特异性着色颗粒。结论已建立了一种HCMV中和抗体效价检测方法,该方法快速、客观,精密性高,耐用性好,专属性强,可用于血浆和IVIG中HCMV中和抗体效价的检测。 Objective To develop a method for detection of neutralizing antibody titer against human cytomegalovirus(HCMV).Methods Serially diluted test samples were mixed with HCMV at an equal volume respectively for neutralization for 1 h,inoculated to MRC-5 cells and incubated at 37℃ overnight,then added with anti-HCMV IE1 McAb,Biotin-SP-Goat anti Mouse IgG,Peroxidase-Labeled Streptavidin and substrate in turn.The nuclei of cells infected with HCMV were stained specifically and observed for location.The infected cells in each well were counted by microscopy.The neutralizing titers of test samples were calculated by Reed-Muench method.The developed method was verified for precision,serviceability and specificity.Results MRC-5 cells infected with HCMV showed typical CPEs,of which the nuclei were stained specifically,while no stained particles were observed in uninfected cells.The variation coefficient of detection result by the developed method in reproducibility test was 3.26%,while that in intermediate precision test was 1.05%.After the test samples were neutralized with an equal volume of neutralizing virus liquid at 37℃ for 55,60 and 65 min,the neutralizing antibody titers showed no significant difference(P 〉 0.05).No specifically stained particles were observed in the MRC-5 cells infected with varicella virus,or in the plasma,IVIG or CMV-IVIG samples after co-incubation with MRC-5 cells.Conclusion A method for detection of neutralizing antibody titer against HCMV was developed,which was rapid,objective,and of high precision,serviceability and specificity,and might be used for the detection of neutralizing antibody titer against HCMV in plasma and IVIG.
出处 《中国生物制品学杂志》 CAS CSCD 2011年第7期849-852,共4页 Chinese Journal of Biologicals
关键词 巨细胞病毒 中和抗体 免疫球蛋白 Cytomegalovirus; Neutralizing antibody; Immunoglobulin
  • 相关文献

参考文献10

  • 1Fang FQ, Fan QS, Yang ZJ, et al. Incidence of eytomegalovims inteetion in Shanghai, China [J]. Clin Vaccine lmmunnl, 2009, 16 (11): 1700-1703.
  • 2Zhong J, Rist M, Cooper L, et ol. Induction of pluripotent protective immunity following immunisation with a chimeric vaccine against human cytomegalovirus [J ]. PLoS One, 2008, 3 (9) : e3256- e3278,.
  • 3Zamora MR, Nicolls MR, Hodges TN, et d. Following universal prophylaxis with intravenous ganciclovir and cytomegalovims im- nmne globulin, valganciclovir is sate and effective tbr prevention of CMV infection following lung transplantation [J]. Am J Transplant, 2004, 4 (10): 1635-1642.
  • 4Gonczol E, Furlini G, Ianaeone J, etal. A rapid microneutralization assay for cytomegalovirus [J]. J Virol Methods, 1986, 14 (1): 37-41.
  • 5Chou SW, Scott KM. Rapid quantitation of cytomegalovinls and assay of neutralizing antibody by using monoclonal antibody to the major immediate-early viral protein [J]. J Clin Microbiol, 1988, 26 (3) : 504-507.
  • 6Plummer G, Benyesh-Melniek M. A plaque reduction neutraliza- tion test for human eytomegalovirus [J]. Proe Soe Exp Biol IVied, 1964, 117: 145-150.
  • 7Bernstein DI, Schleiss MR, Berene, si K, ctal. Etlect of previous or simultaneous immunization with canarypox expressing cytomegalovirus (CMV) glyeoprotein B (gB) on response to subunit gB vaccine plus MF59 in healthy CMV-seronegative adults [J]. J Iufect Dis, 2002,185 (5) : 686-690.
  • 8Marschal M, Freitag M, Weiler S, et al. Recombinant green fhlo rescent protein-expressing human cytomegalovirus as a tool for screening antiviral agents [J]. Antimicroh Agents Chetnother,2000, 44 (6): 1588-1597.
  • 9Andreoni M, Faircloth M, Vugler L, et al. A rapid microneulral- ization assay for the measurement of neutralizing antibody reactive with human cytomegalovirus [J]. J Virol Methods, 1989, 23 (2): 157-167.
  • 10WHO. Guidelines for plaque reduction neutralization testing of human antibodies to dengue viruses IS [S] http: //wwv,.who.int/ vaccines-documents/.

同被引文献56

  • 1郭立君,邵华,陈子杨,李冰,郭凤云.人巨细胞病毒免疫球蛋白的研制及其临床应用[J].微生物学杂志,2004,24(5):29-30. 被引量:2
  • 2赖永榕,卢玉英,陈德全,蒋心武,张良明,李忠.广西地区795名献血员巨细胞病毒抗体检测[J].广西医科大学学报,1994,11(3):286-288. 被引量:9
  • 3张俊玲,王明丽.人巨细胞病毒蚀斑实验条件的优化及在抗病毒物质活性测定中的应用[J].安徽医科大学学报,2007,42(5):485-489. 被引量:6
  • 4Griffiths PD, Grundy JE. Molecular biology and im- munology of eytomegalovirus I-J~. Biochem J, 1987, 241(2) : 313-324.
  • 5Krause PR, Bialek SR, Boppana SB,et al. Priorities for CMV vaeeine development EJ']- Vaeeine, 2013, 32 (1):4-10.
  • 6McVoy MA. Cytomegalovirus Vaccines EJJ. Clinical Infectious Diseases, 2013, 57 ($4) :S196-199.
  • 7Steininger C. Clinical relevance of cytomegalovirus in- fection in patients with disorders of the immune systemEJ]- Clin Microbiol Infect, 2007,13 (10) .. 953-963.
  • 8DAdler SP1, Nigro G. Findings and conclusions from CMV hyperimmune globulin treatment trials [J]. J Clin Virol, 2009,46 (Suppl 4) ..$54-57.
  • 9Polilli E1, Parruti G, D'Arcangelo F, et al. Prelimi- nary evaluation of the safety and efficacy of standardintravenous immunoglobulins in pregnant women with primary cytomegalovirus infection[J]. Clin Vac- cine Immunol, 2012,19(12) : 1991-1993.
  • 10Marshall GS,Rabalais GP,Stout GG,et al.Antibodies to recombinant-derived glycoprotein B after natural human cytomegalovirus infection correlate with neutralizing activity[J].J Infect Dis,1992,165(2):381-384.

引证文献11

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部